TY - JOUR
T1 - Daily morphine administration increases impulsivity in rats responding under a 5-choice serial reaction time task
AU - Maguire, Dr
AU - Henson, C.
AU - France, Cp
N1 - Publisher Copyright:
© 2016 The British Pharmacological Society.
PY - 2016/4/1
Y1 - 2016/4/1
N2 - Background and Purpose Repeated administration of a μ opioid receptor agonist can enhance some forms of impulsivity, such as delay discounting. However, it is unclear whether repeated administration alters motor impulsivity. Experimental Approach We examined the effects of acute administration of morphine and amphetamine prior to and during daily morphine administration in rats responding under a five-choice serial reaction time task. Rats (n = 5) were trained to detect a brief flash of light presented randomly in one of five response holes; responding in the target hole delivered food, whereas responding in the wrong hole or responding prior to illumination of the target stimulus (premature response) initiated a timeout. Premature responding served as an index of motor impulsivity. Key Results Administered acutely, morphine (0.1-10 mg·kg-1, i.p.) increased omissions and modestly, although not significantly, premature responding without affecting response accuracy; amphetamine (0.1-1.78 mg·kg-1, i.p.) increased premature responding without changing omissions or response accuracy. After 3 weeks of 10 mg·kg-1·day-1 morphine, tolerance developed to its effects on omissions whereas premature responding increased approximately fourfold, compared with baseline. Effects of amphetamine were not significantly affected by daily morphine administration. Conclusions and Implications These data suggest that repeated administration of morphine increased effects of morphine on motor impulsivity, although tolerance developed to other effects, such as omissions. To the extent that impulsivity is a risk factor for drug abuse, repeated administration of μ opioid receptor agonists, for recreational or therapeutic purposes, might increase impulsivity and thus the risk for drug abuse.
AB - Background and Purpose Repeated administration of a μ opioid receptor agonist can enhance some forms of impulsivity, such as delay discounting. However, it is unclear whether repeated administration alters motor impulsivity. Experimental Approach We examined the effects of acute administration of morphine and amphetamine prior to and during daily morphine administration in rats responding under a five-choice serial reaction time task. Rats (n = 5) were trained to detect a brief flash of light presented randomly in one of five response holes; responding in the target hole delivered food, whereas responding in the wrong hole or responding prior to illumination of the target stimulus (premature response) initiated a timeout. Premature responding served as an index of motor impulsivity. Key Results Administered acutely, morphine (0.1-10 mg·kg-1, i.p.) increased omissions and modestly, although not significantly, premature responding without affecting response accuracy; amphetamine (0.1-1.78 mg·kg-1, i.p.) increased premature responding without changing omissions or response accuracy. After 3 weeks of 10 mg·kg-1·day-1 morphine, tolerance developed to its effects on omissions whereas premature responding increased approximately fourfold, compared with baseline. Effects of amphetamine were not significantly affected by daily morphine administration. Conclusions and Implications These data suggest that repeated administration of morphine increased effects of morphine on motor impulsivity, although tolerance developed to other effects, such as omissions. To the extent that impulsivity is a risk factor for drug abuse, repeated administration of μ opioid receptor agonists, for recreational or therapeutic purposes, might increase impulsivity and thus the risk for drug abuse.
UR - http://www.scopus.com/inward/record.url?scp=84959263946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84959263946&partnerID=8YFLogxK
U2 - 10.1111/bph.13434
DO - 10.1111/bph.13434
M3 - Article
C2 - 26776751
AN - SCOPUS:84959263946
SN - 0007-1188
VL - 173
SP - 1350
EP - 1362
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 8
ER -